|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD, Fedewa SA, Ahnen DJ,
Meester RGS, Barzi A and Jemal A: Colorectal cancer statistics,
2017. CA Cancer J Clin. 67:177–193. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Vatandoust S, Price TJ and Karapetis CS:
Colorectal cancer: Metastases to a single organ. World J.
Gastroenterol. 21:11767–11776. 2015.
|
|
4
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen D, Li Z, Yang Q, Zhang J, Zhai Z and
Shu HB: Identification of a nuclear protein that promotes NF-kappaB
activation. Biochem Biophys Res Commun. 310:720–724. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pajerowski AG, Nguyen C, Aghajanian H,
Shapiro MJ and Shapiro VS: NKAP is a transcriptional repressor of
notch signaling and is required for T cell development. Immunity.
30:696–707. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Thapa P, Das J, Mcwilliams D, Shapiro M,
Sundsbak R, Nelson-Holte M, Tangen S, Anderson J, Desiderio S,
Hiebert S, et al: The transcriptional repressor NKAP is required
for the development of iNKT cells. Nat Commun. 4:15822013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hsu FC, Pajerowski AG, Nelson-Holte M,
Sundsbak R and Shapiro VS: NKAP is required for T cell maturation
and acquisition of functional competency. J Exp Med. 208:1291–1304.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pajerowski AG, Shapiro MJ, Gwin K,
Sundsbak R, Nelson-Holte M, Medina K and Shapiro VS: Adult
hematopoietic stem cells require NKAP for maintenance and survival.
Blood. 116:2684–2693. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Thapa P, Chen MW, Mcwilliams DC, Belmonte
P, Constans M, Sant'Angelo DB and Shapiro VS: NKAP regulates
invariant NKT cell proliferation and differentiation into
ROR-γt-expressing NKT17 cells. J Immunol. 196:4987–4998. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Burgute BD, Peche VS, Steckelberg AL,
Glöckner G, Gaßen B, Gehring NH and Noegel AA: NKAP is a novel
RS-related protein that interacts with RNA and RNA binding
proteins. Nucleic Acids Res. 42:3177–3193. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li T, Chen L, Cheng J, Dai J, Huang Y,
Zhang J, Liu Z, Li A, Li N, Wang H, et al: SUMOylated NKAP is
essential for chromosome alignment by anchoring CENP-E to
kinetochores. Nat Commun. 7:129692016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wu QB and Sun GP: Expression of COX-2 and
HER-2 in colorectal cancer and their correlation. World J
Gastroenterol. 21:6206–6214. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cotter TG: Apoptosis and cancer: The
genesis of a research field. Nat Rev Cancer. 9:501–507. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tang X, Zha L, Li H, Liao G, Huang Z, Peng
X and Wang Z: Upregulation of GNL3 expression promotes colon cancer
cell proliferation, migration, invasion and epithelial-mesenchymal
transition via the Wnt/β-catenin signaling pathway. Oncol Rep.
38:2023–2032. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu J, Wang H, Yin Y, Li Q and Zhang M:
NKAP functions as an oncogene and its expression is induced by
CoCl2 treatment in breast cancer via AKT/mTOR signaling
pathway. Cancer Manag Res. 10:5091–5100. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Oguma K, Oshima H, Aoki M, Uchio R, Naka
K, Nakamura S, Hirao A, Saya H, Taketo MM and Oshima M: Activated
macrophages promote Wnt signalling through tumour necrosis
factor-alpha in gastric tumour cells. EMBO J. 27:1671–1681. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Amado NG, Predes D, Moreno MM, Carvalho
IO, Mendes FA and Abreu JG: Flavonoids and Wnt/β-catenin signaling:
Potential role in colorectal cancer therapies. Int J Mol Sci.
15:12094–12106. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Saito T, Masuda N, Miyazaki T, Kanoh K,
Suzuki H, Shimura T, Asao T and Kuwano H: Expression of EphA2 and
E-cadherin in colorectal cancer: Correlation with cancer
metastasis. Oncol Rep. 11:605–611. 2004.PubMed/NCBI
|
|
21
|
Murray L: The role of E-cadherin in colon
cancer drug resistanceUniv Glasgow; 2010
|
|
22
|
Kwak JM, Min BW, Lee JH, Choi JS, Lee SI,
Park SS, Kim J, Um JW, Kim SH and Moon HY: The prognostic
significance of E-cadherin and liver intestine-cadherin expression
in colorectal cancer. Dis Colon Rectum. 50:1873–1880. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Croce CM and Reed JC: Finally, an
apoptosis-targeting therapeutic for cancer. Cancer Res.
76:5914–5920. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fesik SW: Promoting apoptosis as a
strategy for cancer drug discovery. Nat Rev Cancer. 5:876–885.
2005. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Huang Q, Li S, Cheng P, Deng M, He X, Wang
Z, Yang CH, Zhao XY and Huang J: High expression of anti-apoptotic
protein Bcl-2 is a good prognostic factor in colorectal cancer:
Result of a meta-analysis. World J Gastroenterol. 23:5018–5033.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Parrish AB, Freel CD and Kornbluth S:
Cellular mechanisms controlling caspase activation and function.
Cold Spring Harb Perspect Biol. 5:2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Igney FH and Krammer PH: Death and
anti-death: Tumour resistance to apoptosis. Nat Rev Cancer.
2:277–288. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gui D, Guo Y, Wang F, Liu W, Chen J, Chen
Y, Huang J and Wang N: Astragaloside IV, a novel antioxidant,
prevents glucose-induced podocyte apoptosis in vitro and in vivo.
PLoS One. 7:e398242012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Martinou JC and Youle RJ: Mitochondria in
apoptosis: Bcl-2 family members and mitochondrial dynamics. Dev
Cell. 21:92–101. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wu R, Tang S, Wang M, Xu X, Yao C and Wang
S: MicroRNA-497 induces apoptosis and suppresses proliferation via
the Bcl-2/Bax-caspase9-caspase3 pathway and cyclin D2 protein in
HUVECs. PLoS One. 11:e01670522016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
He C and Klionsky DJ: Regulation
mechanisms and signaling pathways of autophagy. Annu Rev Genet.
43:67–93. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
White E: Deconvoluting the
context-dependent role for autophagy in cancer. Nat Rev Cancer.
12:401–410. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
White E: The role for autophagy in cancer.
J Clin Invest. 125:42–46. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Burman C and Ktistakis NT: Autophagosome
formation in mammalian cells. Semin Immunopathol. 32:397–413. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tan S, Shi H, Ba M, Lin S, Tang H, Zeng X
and Zhang X: miR-409-3p sensitizes colon cancer cells to
oxaliplatin by inhibiting Beclin-1-mediated autophagy. Int J Mol
Med. 37:1030–1038. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Jiang QG, Li TY, Liu DN and Zhang HT:
PI3K/Akt pathway involving into apoptosis and invasion in human
colon cancer cells LoVo. Mol Biol Rep. 41:3359–3367. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Malinowsky K, Nitsche U, Janssen KP, Bader
FG, Späth C, Drecoll E, Keller G, Höfler H, Slotta-Huspenina J and
Becker KF: Activation of the PI3K/AKT pathway correlates with
prognosis in stage II colon cancer. Br J Cancer. 110:2081–2089.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Alao JP: The regulation of Cyclin D1
degradation: Roles in cancer development and the potential for
therapeutic invention. Mol Cancer. 6:242007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Jiang BH: PI3K/AKT and mTOR/p70S6K1
signaling pathways in human cancer. Curr Cancer Drug Targets.
13:2332013. View Article : Google Scholar : PubMed/NCBI
|
